Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuofeng Li

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Cancer Immunology, Immunotherapy : CII|October 2, 2024
Effectiveness, safety, and biomarker analysis of lenvatinib plus toripalimab as chemo-free therapy in advanced intrahepatic cholangiocarcinoma: a real-world studyShanshan Wang, Jiashuo Chao, Hao Wang, et al.
Chinese Medical Journal|March 11, 2026
Global research landscape and trends of immunotherapy in biliary tract cancersShuofeng Li, Guanhua Yu, Shi Feng, et al.
Cancer Immunology, Immunotherapy : CII|May 30, 2025
Efficacy and safety of local-regional therapy combined with chemotherapy, immune checkpoint inhibitors and lenvatinib as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter retrospective cohort studyShuofeng Li, Guanhua Yu, Mingming Wang, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 2025
Immunotherapy change overcomes acquired resistance after chemo-immunotherapy in unresectable biliary tract cancerXiangqi Chen, Zixiang Zhou, Shuofeng Li, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Local-regional therapy plus ICIs, chemotherapy, and lenvatinib versus ICIs plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter studyMingming Wang, Shuofeng Li, Guanhua Yu, et al.
Cancer Immunology, Immunotherapy : CII|July 15, 2025
Local-regional therapy combined with immune checkpoint inhibitors and lenvatinib versus immune checkpoint inhibitors plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter cohort studyShuofeng Li, Guanhua Yu, Mingming Wang, et al.
Gut|October 28, 2025
Dynamic urinary proteomics integrates single-cell and spatial transcriptomics to reveal tumour microenvironment and predict immunotherapy response in biliary tract cancerShanshan Wang, Zhengguang Guo, Boyu Sun, et al.
Hepatology (Baltimore, Md.)|December 10, 2025
Spatiotemporal landscape of intrahepatic cholangiocarcinoma liver metastasis at the single-cell levelZiyu Xun, Hao Wang, Zhengfeng Xuan, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Cancer Immunology, Immunotherapy : CII|October 2, 2024
Effectiveness, safety, and biomarker analysis of lenvatinib plus toripalimab as chemo-free therapy in advanced intrahepatic cholangiocarcinoma: a real-world studyShanshan Wang, Jiashuo Chao, Hao Wang, et al.
Chinese Medical Journal|March 11, 2026
Global research landscape and trends of immunotherapy in biliary tract cancersShuofeng Li, Guanhua Yu, Shi Feng, et al.
Cancer Immunology, Immunotherapy : CII|May 30, 2025
Efficacy and safety of local-regional therapy combined with chemotherapy, immune checkpoint inhibitors and lenvatinib as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter retrospective cohort studyShuofeng Li, Guanhua Yu, Mingming Wang, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 2025
Immunotherapy change overcomes acquired resistance after chemo-immunotherapy in unresectable biliary tract cancerXiangqi Chen, Zixiang Zhou, Shuofeng Li, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Local-regional therapy plus ICIs, chemotherapy, and lenvatinib versus ICIs plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter studyMingming Wang, Shuofeng Li, Guanhua Yu, et al.
Cancer Immunology, Immunotherapy : CII|July 15, 2025
Local-regional therapy combined with immune checkpoint inhibitors and lenvatinib versus immune checkpoint inhibitors plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter cohort studyShuofeng Li, Guanhua Yu, Mingming Wang, et al.
Gut|October 28, 2025
Dynamic urinary proteomics integrates single-cell and spatial transcriptomics to reveal tumour microenvironment and predict immunotherapy response in biliary tract cancerShanshan Wang, Zhengguang Guo, Boyu Sun, et al.
Hepatology (Baltimore, Md.)|December 10, 2025
Spatiotemporal landscape of intrahepatic cholangiocarcinoma liver metastasis at the single-cell levelZiyu Xun, Hao Wang, Zhengfeng Xuan, et al.
Pageof 7